+1 (319) 433-6210 contact@medicaldevicesandpharma.com
Medical Devices and Pharma
  • Home
  • Consumer
    • Consumer News
    • Food and Beverage
    • Supplements
  • Regulatory
    • Regulatory Services
    • Medical Devices
    • Pharma
    • Biologics
    • Combination Products
    • Veterinary
  • Quality
    • Quality
    • QSR-to-QMSR
  • News
    • Latest
    • Alerts
  • Contact
Select Page

FDA’s Orphan Drug Program

by Bruce Waldon | May 5, 2024 | FDA_Programs, Industry Information, Pharmaceuticals, Product-Innovation, Products_biologics, Products_Devices, Products_Drugs, Reg_Products, US-FDA

FDA's Orphan Drug Program To encourage the development of drugs and biologics for rare diseases or conditions Home About Consumer Medical Devices Pharma AI Regulatory Quality QMSR Central News Enforcement Alerts Innovation Contact Expedite Development of New Orphan...

Rare Pediatric Disease Priority Review Voucher program 

by Bruce Waldon | May 5, 2024 | FDA_Programs, Industry Information, Pharmaceuticals, US-FDA

Rare Pediatric Disease Priority Review Voucher (PRV) program To expedite the review and approval of pediatric disease therapies Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation My Account Contact Expedite Development...

Key FDA Congressional Legislation 

by Bruce Waldon | May 5, 2024 | FDA_Legislation, Industry Information, US-FDA

Navigating Complex Regulations History of Congressional Legislation for FDA Several significant congressional legislative actions have directly affected the establishment, oversight authority, and processes of the US Food and Drug Administration (FDA). As a component...

Medical Devices and Pharmaceuticals

by Bruce Waldon | May 3, 2024 | Industry Information, Med-Devices, Pharmaceuticals, US-FDA

Navigating Complex Regulations Regulatory Guidance for Medical Devices & Pharmaceuticals At Medical Devices and Pharma, we specialize in providing top-tier regulatory consulting services tailored to the medical device and pharmaceutical industries. Our deep...

Tisotumab Vedotin-tftv for Recurrent or Metastatic Cervical Cancer 

by Bruce Waldon | May 3, 2024 | FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA

Drug Innovation - Tisotumab vedotin-tftv, marketed as Tivdak For Recurrent or Metastatic Cervical Cancer Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact Product Approval for Cervical Cancer Drug   Exciting...

FDA Approves Anktiva for Bladder Cancer 

by Bruce Waldon | May 3, 2024 | Consumer Information, FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA

FDA Drug Innovation - Anktiva Treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact New Drug Approval  In a significant development for...
« Older Entries
Next Entries »

QMSR

Regulatory

Quality

Consumer

MDP Facebook page
LinkedIn logo
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}